LTR Pharma to Present SPONTAN® Clinical Results at Major Upcoming Urological Conference
By API User
LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that its Chief Scientific and Clinical Advisor, Professor Eric Chung, will present pivotal SPONTAN® clinical trial data at the Urological Society of Australia and New Zealand (USANZ) Annual Scientific Meeting in Perth, from 1 to 4 March 2025. Highlights 470% Faster Absorption: … Continued